Free Contraception May Turn-Out Votes in November, but few women have to News Turned to Learn Whats Covered

Durham, NC (PRWEB) 10 October 2012 Effective 1 August this year, 47 million women were entitled to free preventive services begin under the Affordabl...


Durham, NC (PRWEB) 10 October 2012

Effective 1 August this year, 47 million women were entitled to free preventive services begin under the Affordable Care Act (ACA) and may, in their health plans, the next enrollment period. All FDA-approved contraceptive methods, including hormonal pills, patches, loops and IUSS are covered. For most women who have a co-payment for their contraception result in an average savings of $ 200 per year. But 360 after the Phoenix Marketing? Birth Control Market Tracking program, only 36% of women who currently use or plan to use prescription contraception even after the news of the Affordable Care Act. This represents a significant shortfall in the education of women on the program as well as a huge opportunity for providers of prescription birth control products that can best target this audience.

Phoenix Healthcare, a division of Phoenix Marketing International, interviews 1,000 women at the birth control market every month to find out what they use, when and if they plan to switch brands or methods together with tracking their use of branded products DTC ads lead to what. contraceptive methods and products that they talk to their doctor about

Phoenix Healthcare birth control audit is part of a growing family of disease category consumer studies that offer exclusive Phoenix 360? Market View Top. Phoenix Healthcare 360? MarketView studies currently cover 40% of all DTC spending in the United States with the research in the following categories:. Contraceptives, dyslipidemia, schizophrenia, rheumatoid arthritis, plaque psoriasis, Crohn’s disease, psoriatic arthritis, ankylosing spondylitis, and Mens Health Pursues a partial list of the most important brands in these programs include: Abilify, Actemra, AndroGel, Cialis, Cimzia, Ella, Enbrel, Essure, Generess FE, Humira, Invega Sustenna, Januvia, Levitra, Lo Loestrin FE, Mirena, Niaspan, Orencia, Ortho Evra and Ortho Tricyclic Lo, ParaGard, Plan B, Rapiflo, Remicade, Rituxan, Seroquel XR, Simponi, Stelara, Uloric, Viagra, Victoza and Zyprexa Relprevv.

For more information on the nature of the brand tracking information in the 360? Contraceptive Market View? Study contact John Duggan at 508-315-6184.


Leave a Reply